Investing
1489 Articles
Disney, Intel, Pfizer, and Verizon led Tuesday's drop in the DJIA.
One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…
The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…
Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar…
When Pfizer released its third-quarter earnings report before the markets opened on Tuesday, the results and guidance lived up to…
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
The busiest earnings week of the season has come and gone, but there are still plenty more big names stepping…
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November…
The October 13 short interest data have been compared with the previous figures, and short interest in most of these…
Among the most shorted stocks traded on the New York Stock Exchange, two struggling retailers saw notable growth in their…
Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that…
The September 29 short interest data have been compared with the previous figures, and short interest in most of these…
The September 15 short interest data have been compared with the previous figures, and short interest in most of these…
If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech…
Apple and 3M weighed on the DJIA Wednesday while McDonald's and Pfizer gave the index a boost.
Our top personal finance-related articles today. Your wallet will thank you later.